Congenital infections associated with international travel during pregnancy

Journal of Travel Medicine

Volumn 14, Issue 2, 2007, Pages 117-128

  McGovern, Lauren M ^a   Boyce, Thomas G ^a   Fischer, Philip R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ATOVAQUONE PLUS PROGUANIL; DOXYCYCLINE; ETHAMBUTOL; HEPATITIS VACCINE; ISONIAZID; JAPANESE ENCEPHALITIS VACCINE; MEFLOQUINE; PRIMAQUINE; PYRIMETHAMINE; RIFAMPICIN; RUBELLA VACCINE; SPIRAMYCIN; SULFADIAZINE; TYPHOID VACCINE; YELLOW FEVER VACCINE; ZIDOVUDINE;

AFRICAN TRYPANOSOMIASIS; ANTIBIOTIC PROPHYLAXIS; BODY FLUID; CHAGAS DISEASE; CONGENITAL INFECTION; DENGUE; EPIDEMIC ENCEPHALITIS; FILARIASIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMOLYSIS; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYGIENE; INFECTION; INFECTION PREVENTION; INSECT CONTROL; LEISHMANIASIS; LEPTOSPIROSIS; MALARIA; NEWBORN PERIOD; PREGNANCY; REVIEW; RUBELLA; TOXOPLASMOSIS; TUBERCULOSIS; TYPHOID FEVER; VACCINATION; YELLOW FEVER;

FEMALE; HUMANS; INFANT, NEWBORN; INFECTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TRAVEL;

EID: 33947245448     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2006.00093.x     Document Type: Review

References (90)

1. Kingman CE, Economides DL. Travel in pregnancy: pregnant women's experiences and knowledge of health issues. J Travel Med 2003;10:330-333.
2. Shetty AK, Maldonado Y. Preventing mother-to-child transmission of human immunodeficiency virus type 1 in resource-poor countries. Pediatr Infect Dis J 2003;22:553-555.
3. Smith KC. Congenital tuberculosis: a rare manifestation of a common infection. Curr Opin Infect Dis 2002;15:269-274.
4. Shah S, Filler S, Causer LM, et al. Malaria surveillance - United States, 2002. MMWR Surveill Summ 2004;53:21-34.
5. Legros S, Danis M. Surveillance of malaria in European Union countries. Euro Surveill 1998;3:45-47.
6. Fischer PR. Congenital malaria: an African survey. Clin Pediatr (Phila) 1997;36:411-413.
7. Newman R, Hailemariam A, Jimma D, et al. Burden of malaria during pregnancy in areas of stable and unstable transmission in Ethiopia during a nonepidemic year. J Infect Dis 2003;187:1765-1772.
8. Fisher RG, Boyce TG. Moffet's pediatric infectious diseases. 4th Ed. Philadelphia: Lippincott Williams & Wilkins, 2005.
9. Dorman EK, Shulman CE, Kingdom J, et al. Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria. Ultrasound Obstet Gynecol 2002;19:165-170.
10. Fischer PR. Malaria and newborns. J Trop Pediatr 2003;49:132-134.
11. Lindsay S, Ansell J, Selman C, et al. Effect of pregnancy on exposure to malaria mosquitoes. Lancet 2000;355:1972.
12. Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 1996;272:1502-1504.
13. Redd SC, Wirima JJ, Steketee RW, et al. Transplacental transmission of Plasmodium falciparum in rural Malawi. Am J Trop Med Hyg 1996;55(Suppl):57-60.
14. Kamwendo DD, Dzinjalamala FK, Snounou G, et al. Plasmodium falciparum: PCR detection and genotyping of isolates from peripheral, placental, and cord blood of pregnant Malawian women and their infants. Trans R Soc Trop Med Hyg 2002;96:145-149.
15. Dolan G, Ter Kuile FO, Jacoutot V, et al. Bed nets for the prevention of malaria and anaemia in pre gnancy. Trans R Soc Trop Med Hyg 1993;87:620-626.
16. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev 2004;2:CD000363.
17. McGready R, Hamilton K, Simpson J, et al. Safety of the insect repellent N,N-diethyl-M-toluamide (DEET) in pregnancy. Am J Trop Med Hyg 2001;65:285-289.
18. Smoak B, Writer J, Keep L, et al. The effects of inadvertent exposure of mefloquine chemoprophalaxis on pregnancy outcomes and infants of US Army servicewomen. J Infect Dis 1997;176:831-833.
19. Shulman CE, Dorman EK. Importance and prevention of malaria in pregnancy. Trans R Soc Trop Med Hyg 2003;97:30-35.
20. Center for Disease Control and Prevention. Health information for the international traveler, yellow fever. Available at: http://www2.ncid.cdc.gov/ travel/yb/utils/ybGet.asp?section=dis&obj=yellowfever.htm. (Accessed 2005 Oct 11)
21. Tsai TF, Paul R, Lynberg C, Letson W. Congenital yellow fever virus infection after immunization in pregnancy. J Infect Dis 1993;168:1520-1523.
22. World Health Organization. International travel and health publication. Available at: http://www.who.int/ith/en/. (Accessed 2005 Oct 10)
23. Nishioka Sde A, Nunes-Araujo FR, Pires WP, et al. Yellow fever vaccination during pregnancy and spontaneous abortion: a case-control study. Trop Med Int Health 1998;3:29-33.
24. Nasidi A, Monath TP, Vanderberg J, et al. Yellow fever vaccination and pregnancy: a four-year prospective study. Trans R Soc Trop Med Hyg 1993;87:337-339.
25. Suzano C, Amaral E, Sato H, Papairordanou P. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during mass campaign in Brazil. Vaccine 2006;24:1421-1426.
26. Cetron MS, Marfin A, Julian K, et al. Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002. MMWR Recomm Rep 2002;51:1-11.
27. Leikin E, Lysikiewicz A, Garry D, Tejani N. Intrauterine transmission of hepatitis A virus. Obstet Gynecol 1996;88:690-691.
28. Pickering LK, ed. Red Book: 2003 report of the committee on infectious diseases. 26th Ed. Elk Grove Village, IL: American Academy of Pediatrics, 2003.
29. Remington J, Klein J. Infectious disease of the fetus and newborn infant. 5th Ed. Philadelphia: WB Saunders, 2001.
30. Mast E, Margolis H, Fiore A, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR Morb Mortal Wkly Rep 2005;54(RR16):1-23. Available at: http://www.cdc.gov/ mmwr/preview/mmwrhtml/rr5416a1.htm. (Accessed 2006 Apr 6)
31. Duff P. Hepatitis in pregnancy. Semin Perinatol 1998;22:277-283.
32. Okada K, Kamiyama I, Inomata M, et al. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976;294:746-749.
33. Stevens CE, Taylor P, Tong M, et al. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987;257:2612-2616.
34. Levy M, Koren G. Hepatitis B vaccine in pregnancy: maternal and fetal safety. Am J Perinatol 1991;8:227-232.
35. Bortolotti F, Resti M, Giacchino R, et al. Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Pediatr 1997;130:990-993.
36. Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet 1995;345:289-291.
37. Ohto H, Terazawa S, Sasaki N, et al. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med 1994;330:744-750.
38. Schackman B, Oneda K, Goldie S. The cost-effectiveness of elective Cesarean delivery to prevent hepatitis C transmission in HIV-coinfected women. AIDS 2004;18:1827-1834.
39. Singh S, Mohanty A, Joshi YK, et al. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 2003;70:37-39.
40. Kumar RM, Uduman S, Rana S, et al. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001;100:9-15.
41. Kumar A, Beniwal M, Kar P, et al. Hepatitis E in pregnancy. Int J Gynecol Obstet 2004;85:240-244.
42. Tsega E, Krawczynski K, Hansson B, Nordenfelt E. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J 1993;31:173-181.
43. Meinecke CK, Schottelius J, Oskam L, Fleischer B. Congenital transmission of visceral leishmaniasis (Kala Azar) from an asymptomatic mother to her child. Pediatrics 1999;104:e65.
44. Pagliano P, Carannante N, Rossi M, et al. Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature. J Antimicrob Chemother 2005;55:229-233.
45. Mellor AL, Munn DH. Immunology at the maternal-fetal interface: lessons for T cell tolerance and suppression. Annu Rev Immunol 2000;18:367-391.
46. Sobel J. Use of antifungal drugs in pregnancy, a focus on safety. Drug Saf 2000;23:77-85.
47. Martin S. Congenital toxoplasmosis. Neonatal Netw 2001;20:23-30.
48. Dunn D, Wallon M, Peyron F, et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999;353:1829-1833.
49. Guerina NG, Hsu H, Meissner C, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994;330:1858-1863.
50. Cook AJ, Gilbert R, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000;321:142-147.
51. Gilbert R, Gras L. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003;110:112-120.
52. Montoya J. Toxoplasmosis. Lancet 2004;363:1965-1976.
53. Center for Disease Control and Prevention. Health information for the international traveler, lymphatic filariasis. Available at: http://www2.ncid. cdc.gov/travel/yb/utils/ybGet.asp?section=dis&obj=filariasis. htm. (Accessed 2005 Oct 11)
54. Fonticiella M, Lopez-Negrete L, Prieto A, et al. Congenital intracranial filariasis: a case report. Pediatr Radiol 1995;25:171-172.
55. Eberhard ML, Hitch W, McNeeley D, Lammie P. Transplacental transmission of Wuchereria bancrofti in Haitian women. J Parasitol 1993;79:62-66.
56. Chaturvedi UC, Mathur A, Chandra A, et al. Transplacental infection with Japanese encephalitis virus. J Infect Dis 1980;141:712-715.
57. Mathur A, Arora KL, Chaturvedi UC. Congenital infection of mice with Japanese encephalitis virus. Infect Immun 1981;34:26-29.
58. Fujisaki Y, Miura Y, Sugimori T, et al. Experimental studies on vertical infection of mice with Japanese encephalitis virus III. Effect of gestation days at the time of inoculation on placental and fetal infection. Natl Inst Anim Health Q (Tokyo) 1982;22:95-101.
59. Center for Disease Control and Prevention. Elimination of rubella and congenital rubella syndrome - United States, 1969-2004. MMWR Morb Mortal Wkly Rep 2005;54:279-282.
60. Danovaro-Holliday MC, Gordon E, Woernle C, et al. Identifying risk factors for rubella susceptibility in a population at risk in the United States. Am J Public Health 2003;93:289-291.
61. Kaplan C. The placenta and viral infections. Semin Diagn Pathol 1993;10:232-250.
62. Webster WS. Teratogen update: congenital rubella. Teratology 1998;58:13-23.
63. Center for Disease Control and Prevention. Health information for the international traveler, typhoid fever. Available at: http://www2.ncid.cdc.gov/ travel/yb/utils/ybGet.asp?section=dis&obj=typhoid.htm. (Accessed 2005 Oct 11)
64. Carles G, Montoya Y, Seve B, et al. Typhoid fever and pregnancy. J Gynecol Obstet Biol Reprod (Paris) 2002;31:495-499.
65. WHO. Water related diseases. Available at: http://www.who.int/ water_sanitation_health/diseases/leptospirosis/en/. (Accessed 2005 Oct 11)
66. Shaked Y, Shpilberg O, Samra D, Samra Y. Leptospirosis in pregnancy and its effect on the fetus: case report and review. Clin Infect Dis 1993;17:241-243.
67. Dengue Hemorrhagic Fever Surveillance Report, Disease Control Division, Health Department. Bangkok, Thailand: Bangkok Metropolitan Administration, 2003.
68. Sirinavin S, Nuntnarumit P, Supapannachart S, et al. Vertical dengue infection: case reports and review. Pediatr Infect Dis J 2004;23:1042-1047.
69. Stephenson JR. Understanding dengue pathogenesis: implications for vaccine design. Bull World Health Organ 2005;83:308-314.
70. Chaturvedi U, Shrivastava R, Nagar R. Dengue vaccines: problems and prospects. Indian J Med Res 2005;121:639-652.
71. Poms R, Tatini S. Survival of Helicobacter pylori in ready-to-eat foods at 4 degrees C. Int J Food Microbiol 2001;63:281-286.
72. Fujimura S, Kato S, Nagai K, et al. Detection of Helicobacter pylori in the stools of newborn infants. Pediatr Infect Dis J 2004;23:1055-1056.
73. Thomas JE, Dale A, Bunn J, et al. Early Helicobacter pylori colonisation: the association with growth faltering in The Gambia. Arch Dis Child 2004;89:1149-1154.
74. Center for Disease Control and Prevention. Health information for the international traveler, African trypanosomiasis. Available at: http://www2.ncid.cdc.gov/travel/yb/utils/ybGet.asp?section=dis&obj= aftrypano.htm&cssNav=browseoyb. (Accessed 2006 Apr 2)
75. Lingam S, Marshall W, Wilson J, et al. Congenital trypanosomiasis in a child born in London. Dev Med Child Neurol 1985;27:670-674.
76. Olowe SA. A case of congenital trypanosomiasis in Lagos. Trans R Soc Trop Med Hyg 1975;69:57-59.
77. Moretti E, Basso B, Castro I, et al. Chagas' disease: study of congenital transmission in cases of acute maternal infection. Rev Soc Bras Med Trop 2005;38:53-55.
78. Hermann E, Truyens C, Alonso-Vega C, et al. Congenital transmission of Trypanosoma cruzi is associated with maternal enhanced parasitemia and decreased production of interferon-gamma in response to parasite antigens. J Infect Dis 2004;189:1274-1281.
79. Urbina J. Specific treatment of Chagas' disease: current status and new developments. Curr Opin Infect Dis 2001;14:717-718.
80. World Health Organization. Tuberculosis fact sheet. Available at: http://www.who.int/mediacentre/factsheets/fs104/en/. (Accessed 2005 Oct 12)
81. Cantwell MF, Shehab ZM, Costello AM, et al. Brief report: congenital tuberculosis. N Engl J Med 1994;330:1051-1054.
82. Miller KS, Miller JM Jr. Tuberculosis in pregnancy: interactions, diagnosis, and management. Clin Obstet Gynecol 1996;39:120-142.
83. Carter EJ, Mates S. Tuberculosis during pregnancy. The Rhode Island experience, 1987 to 1991. Chest 1994;106:1466-1470.
84. Schaefer G, Zervoudakis IA, Fuchs FF, David S. Pregnancy and pulmonary tuberculosis. Obstet Gynecol 1975;46:706-715.
85. Wilson EA, Thelin TJ, Dilts PV Jr. Tuberculosis complicated by pregnancy. Am J Obstet Gynecol 1973;115:526-529.
86. World Health Organization. HIV in pregnancy: a review. Available at: http://www.who.int/reproductive-health/publications/rhr_99_15/hiv_in_pregnancy. pdf. (Accessed 2005 Oct 12)
87. Koren G, Matsui D, Bailey B. DEET-based insect repellents: safety implications for children and pregnant and lactating women. CMAJ 2003;169:209-212.
88. Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med 2002;347:13-18.
89. Astroff A, Freshwater K, Young A, et al. The conduct of a two-generation reproductive toxicity study via dermal exposure in the Sprague-Dawley rat - a case study with KBR 3023 (a prospective insect repellant). Reprod Toxicol 1999;13:223-232.
90. Center for Disease Control and Prevention. Health information for international travel 2005-2006. Available at: http://www2.ncid.cdc.gov/travel/ yb/utils/ybGet.asp?section=children&obj=breastfeeding.htm&cssNav= browseoyb. (Accessed 2005 Oct 12)